Anixa Biosciences (ANIX) Accumulated Expenses (2010 - 2026)
Anixa Biosciences' Accumulated Expenses was $1.42 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), down 19.1% from $1.75 million a year earlier but up 17.6% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Accumulated Expenses at Anixa Biosciences came in at $1.76 million, down 9.5% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
- In earlier fiscal years, Accumulated Expenses was $1.95 million in FY2024 (+9.9%), $1.77 million in FY2023 (+2.5%), $1.73 million in FY2022 (+57.6%) and $1.1 million in FY2021 (+21.5%).
- Quarterly Accumulated Expenses has moved between $1.06 million (fiscal Q2 2022) and $1.95 million (fiscal Q4 2024) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in four of the last seven quarters, with an average decline of 2.4%.
- The best year-over-year quarter for Accumulated Expenses over five years was fiscal Q4 2022 (growth of 57.6%); the worst was fiscal Q2 2026 (a decline of 23.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.42 Mn |
| Apr 30, 2026 | 1.21 Mn |
| Oct 31, 2025 | 1.76 Mn |
| Jul 31, 2025 | 1.75 Mn |
| Apr 30, 2025 | 1.57 Mn |
| Jan 31, 2025 | 1.36 Mn |
| Oct 31, 2024 | 1.95 Mn |
| Jul 31, 2024 | 1.68 Mn |
| Apr 30, 2024 | 1.41 Mn |
| Jan 31, 2024 | 1.24 Mn |
| Oct 31, 2023 | 1.77 Mn |
| Jul 31, 2023 | 1.71 Mn |
| Apr 30, 2023 | 1.29 Mn |
| Jan 31, 2023 | 1.08 Mn |
| Oct 31, 2022 | 1.73 Mn |
| Jul 31, 2022 | 1.20 Mn |
| Apr 30, 2022 | 1.06 Mn |
| Jan 31, 2022 | 1.24 Mn |
| Oct 31, 2021 | 1.10 Mn |
| Jul 31, 2021 | 989,724.00 |
API Access
Anixa Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();